Reply to Morice and Hart: Increased Propensity for Pneumonia with Fluticasone in Chronic Obstructive Pulmonary Disease
Am J Respir Crit Care Med
.
2018 May 1;197(9):1230-1231.
doi: 10.1164/rccm.201711-2313LE.
Authors
David A Lipson
1
2
,
Helen Barnacle
3
,
Ruby Birk
3
,
Noushin Brealey
3
,
Nicholas Locantore
1
,
David A Lomas
4
,
Andrea Ludwig-Sengpiel
5
,
Rajat Mohindra
3
,
Maggie Tabberer
3
,
Chang-Qing Zhu
3
,
Steven J Pascoe
1
Affiliations
1
1 GSK King of Prussia, Pennsylvania.
2
2 University of Pennsylvania Philadelphia, Pennsylvania.
3
3 GSK Uxbridge, United Kingdom.
4
4 University College London London, United Kingdom and.
5
5 KLB Health Research Lübeck, Germany.
PMID:
29241016
DOI:
10.1164/rccm.201711-2313LE
No abstract available
Publication types
Letter
Comment
MeSH terms
Bronchodilator Agents
Fluticasone
Humans
Pneumonia*
Pulmonary Disease, Chronic Obstructive*
Substances
Bronchodilator Agents
Fluticasone
Grants and funding
MR/N024842/1/MRC_/Medical Research Council/United Kingdom